天弘国证生物医药ETF发起式联接A(011040)份额变动
截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
2024-12-30 |
401,849,764.31 |
459,703,610.91 |
329,103,601.27 |
271,249,754.67 |
2024-09-29 |
366,913,438.23 |
401,849,764.31 |
86,645,764.72 |
51,709,438.64 |
2024-06-29 |
344,401,178.47 |
366,913,438.23 |
61,918,684.72 |
39,406,424.96 |
2024-03-30 |
311,039,184.19 |
344,401,178.47 |
82,476,375.85 |
49,114,381.57 |
2023-12-30 |
260,326,643.34 |
311,039,184.19 |
90,461,724.65 |
39,749,183.80 |
2023-09-29 |
239,914,067.93 |
260,326,643.34 |
54,272,415.20 |
33,859,839.79 |
2023-06-29 |
186,695,567.03 |
239,914,067.93 |
80,117,630.16 |
26,899,129.26 |
2023-03-30 |
179,258,010.31 |
186,695,567.03 |
38,275,709.52 |
30,838,152.80 |
2022-12-30 |
171,930,214.11 |
179,258,010.31 |
38,816,299.54 |
31,488,503.34 |
2022-09-29 |
142,968,174.28 |
171,930,214.11 |
53,636,798.85 |
24,674,759.02 |
2022-06-29 |
138,452,612.71 |
142,968,174.28 |
28,926,196.41 |
24,410,634.84 |
2022-03-30 |
127,303,554.38 |
138,452,612.71 |
36,979,139.09 |
25,830,080.76 |